GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zim Corp (OTCPK:ZIMCF) » Definitions » Beta

Zim (ZIMCF) Beta : -0.83 (As of May. 05, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zim Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-05), Zim's Beta is -0.83.


Zim Beta Historical Data

The historical data trend for Zim's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zim Beta Chart

Zim Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.22 -2.20 2.03 3.07 1.50

Zim Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.81 1.52 1.50 1.21 1.23

Competitive Comparison of Zim's Beta

For the Biotechnology subindustry, Zim's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zim's Beta Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zim's Beta distribution charts can be found below:

* The bar in red indicates where Zim's Beta falls into.



Zim Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Zim  (OTCPK:ZIMCF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Zim Beta Related Terms

Thank you for viewing the detailed overview of Zim's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Zim (ZIMCF) Business Description

Traded in Other Exchanges
N/A
Address
20 Colonade Road, Suite 200, Ottawa, ON, CAN, K2E 7M2
Zim Corp has sold its operations and is currently focused on biomedical research. The company focused all of its resources on developing intellectual property and advancing research and development in the areas of new synthetic drugs and immunotherapies. It generates geographic revenue from Canada.
Executives
John Anthony Chapman officer: Chief Financial Officer 30 HOLITZNER WAY OTTAWA A6 K2G 6V6
Filippo Scavo officer: VP Business Development 1140 STANTON ROAD OTTAWA A6 K2C 3C7
Roberto Campagna officer: VP Retail Sales
Marlen Cowpland 10 percent owner
Bill Parisi officer: VP of Business Development 1530 REINDEER WAY GREELY ONTARIO CANADA D5 K4P1N1
Favero Roderio De officer: VP of Bus Dev - Brazil RUA NILZA MEDEIROS MARTINS 200, BLOCO 4,APR 114 SAO PAULO, BRAZIL D5 05628-010
Donald Gibbs director 239 CHICAGE TRAIL MEDFORD LAKES NJ 08088
Cowpland Michael C J director, 10 percent owner, officer: Pres &, other: CEO C/O ZIM CORP 20 COLONNADE ROAD OTTAWA ONTARIO A6 K2E 7M6
Steven Houck director C/O ZIM CORP 20 COLONNADE ROAD OTTAWA, ONTARIO A6 K2E 7M6
James Stechyson director C/O ZIM CORP 20 COLONNADE ROAD OTTAWA, ONTARIO A6 K2E 7M6
Jennifer North officer: CFO, other: Secretary C/O ZIM CORP 20 COLONNADE ROAD OTTAWA ONTARIO A6 K2E 7M6
Charles Saikaley director C/O ZIM CORP 20 COLONNADE ROAD OTTAWA ONTARIO A6 K2E 7M6
Tony Davidson officer: Chief Technology Officer 74 KNUDSON DRIVE KANATA A6 K2K 2L5
Denise Batson 10 percent owner C/O ZIM CORP 20 COLONNADE ROAD, SUITE 200 NEPEAN A6 K2E 7M6

Zim (ZIMCF) Headlines

From GuruFocus

ZIM Announces Changes in Its Board

By PRNewswire PRNewswire 10-15-2020

ZIM Announces Financial Results For the Second Quarter of 2020

By PRNewswire PRNewswire 08-19-2020

ZIM to Launch a new Mexico - Tampa Shuttle Service in December

By PRNewswire PRNewswire 11-13-2020